ONCY
ONCOLYTICS BIOTECH INC
Key Financials
Net Income
$-28759000
↓ 26.2%
Operating Income
$-28725000
↓ 12.5%
EPS (Diluted)
$-0.30
0.0%
Total Assets
$7.6M
↓ 43.5%
Shareholders' Equity
$-3799000.00
↓ 215.2%
Cash & Equivalents
$5.2M
↓ 53.0%
Total Liabilities
$11.4M
↑ 12.4%
Operating Cash Flow
$-20112000.00
↓ 1.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/13/2026 | View on SEC |
| DEFA14A | 10/6/2026 | View on SEC |
| DEF 14A | 10/6/2026 | View on SEC |
| 8-K | 9/29/2026 | View on SEC |
| 8-K | 9/28/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| 8-K | 8/18/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 7/24/2026 | View on SEC |
| 8-K | 7/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ONCY |
| Company Name | ONCOLYTICS BIOTECH INC |
| CIK | 1129928 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 4036707377 |